Business
Cannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference
Cannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, Aug. 10, 2018\n\n\n\nTEL AVIV, Israel and BETHESDA, Maryland, Aug. 10, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that its CEO, Mr. Eyal Barad, will be attending the Benzinga Cannabis Capital Conference, to be held at the Toronto Arcadian Centre, on August 16th-17th 2018, and will be available for one on one meetings.\n\n\nThe Cannabis Capital Conference is presented by Benzinga, a leading financial media outlet with extensive coverage of the cannabis space. It is a premier gathering of cannabis entrepreneurs and investors in North America.\n\nBenzinga is a financial media outlet that empowers investors with unique content that is recognized by Wall Street traders. Benzinga provides ideas that help navigate the markets – in real-time.\n\nCannabics Pharmaceuticals' CEO was recently featured on Benzinga in an interview by Javier Hasse. The interview can be found here:  Four Questions With Cannabics Pharmaceuticals CEO Eyal Barad.\n\nMore recent articles in which Cannabics was featured, that include additional information on our activities, may be seen on the new website.\n\nEyal Barad, CEO of the company, said: \"The Benzinga Capital Conference offers a unique opportunity to meet and network with Medical Cannabis influencers and policymakers in North America, which hold great potential for future collaborations on various activities. Our goal is to thoroughly explore these potentials\".  \n\nMeeting requests can be sent to: [email protected] \n\nAbout Cannabics: \n\nAbout Cannabics Pharmaceuticals Inc. \n\nCannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer and Palli...